March 2, 2006 — The US Food and Drug Administration (FDA) has approved orphan drug status for amphotericin B inhalation powder in the prevention of pulmonary fungal infections in patients at risk for ...

Am J Health Syst Pharm. 2006;63(18):1704-1716. The toxicity of nebulized amphotericin B was evaluated in 29 patients suffering from prolonged neutropenia. [42] Amphotericin B 30 mg was diluted in 3 mL ...

Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related death in sub-Saharan Africa. Whether a treatment regimen that includes a single high dose of liposomal ...

Voriconazole is a broad-spectrum triazole that is active against aspergillus species. We conducted a randomized trial to compare voriconazole with amphotericin B for primary therapy of invasive ...

In this retrospective study, we investigated the safety and tolerability of a local prophylaxis with aerosolized d-AmB, administered together with systemic antifungal prophylaxis in hematological ...